Wednesday, September 15, 2010

Piper Jaffray Says Arena Pharmaceuticals (ARNA) Sell-Off is an "Overreaction"

Piper Jaffray reiterates their Overweight rating on shares of ARNA with a price target of $10.

http://www.streetinsider.com/Analyst+Comments/Piper+Jaffray+Says+Arena+Pharmaceuticals+%28ARNA%29+Sell-Off+is+an+%22Overreaction%22/5967972.html

No comments:

Post a Comment